Prediagnostic BMI, Plasma C-Peptide Concentration, And Prostate Cancer-Specific Mortality In Men With Prostate Cancer: A Long-Term Survival Analysis

UroToday.com - A significant level of interest has developed in the association of prostate cancer (CaP) specific mortality (PCSM) with nutrition, lifestyle variables, and treatment effects. The data surrounding a man’s body mass index (BMI) and PCSM is mixed, but likely suggest an association between high BMI and an increased risk of dying from CaP. But is there a test that links obesity with this increased risk? In the online edition of Lancet Oncology, Dr. Jing Ma and associates of Dr.

More: continued here

Filed under: Cancer on November 25th, 2008